|
|
Vision Service Codes 92250 and 92341, CR 112321 |
Specialty Services |
|
|
2023 Indian Health Services (IHS) Rate Update, CR 115822 |
General Notifications for All Providers |
|
|
Denials for JCode/NDC Combination, CR 115839 |
Hospital & Clinic Services |
|
|
Maine Center for Disease Control and Prevention (CDC) Webinar on PrEP (Pre-Exposure Prophylaxis) and nPEP (non-occupational Post Exposure Prophylaxis) |
General Notifications for All Providers |
|
|
Attention Section 43 Hospice Providers: Electronic Visit Verification (EVV) Implementation Temporarily Suspended |
Long Term Services and Supports |
|
|
Service Locator Tool – Invitation to Behavioral Health Providers |
Behavioral Health (BH) |
|
|
Electronic Visit Verification (EVV) Trainings and Forums |
Long Term Services and Supports |
|
|
Attention Providers of Section 17 Community Integration Services (CIS), Assertive Community Treatment (ACT) and Section 92 Adult Behavioral Health Homes (BHH) Hold for Service Requirements |
Behavioral Health (BH) |
|
|
CORRECTION: End of the 2022-2023 Seasonal Coverage for Use of Palivizumab Prophylaxis to Prevent Hospitalization from Severe Respiratory Syncytial Virus (RSV) Infection |
Hospital & Clinic Services, Primary Care and Care Coordination, Retail Pharmacies |
|
|
Facility License Renewal Reminder |
General Notifications for All Providers |
|
|
2023 Indian Health Services (IHS) Rate Update, CR 118522 |
General Notifications for All Providers |
|
|
Fiscal Year 2023, Swing Bed and Days Awaiting Placement Rate Updates |
Hospital & Clinic Services |
|
|
Update to the Biosimilar Preferred Drug List |
Hospital & Clinic Services |
|
|
End of the 2022-2023 Seasonal Coverage for Use of Palivizumab Prophylaxis to Prevent Hospitalization from Severe Respiratory Syncytial Virus (RSV) Infection |
Primary Care and Care Coordination |
|
|
End of the 2022-2023 Seasonal Coverage for Use of Palivizumab Prophylaxis to Prevent Hospitalization from Severe Respiratory Syncytial Virus (RSV) Infection |
Hospital & Clinic Services |
|
|
End of the 2022-2023 Seasonal Coverage for Use of Palivizumab Prophylaxis to Prevent Hospitalization from Severe Respiratory Syncytial Virus (RSV) Infection |
Retail Pharmacies |
|
|
Additional Drug Rate Updates, CR 106867 |
General Notifications for All Providers |
|
|
Attention Providers of Section 65, Behavioral Health Services, Crisis Resolution and Response: Draft Service Model and Provider Survey Tool Presented Materials |
Behavioral Health (BH) |
|
|
MaineCare Unwinding Partner Information and Communications Toolkit |
General, All Services |
|
|
Electronic Visit Verification (EVV) Trainings and Forums |
Long Term Services and Supports |